Two ReAct colleagues, Mirfin Mpundu, Head of ReAct Africa, and Otto Cars, founder of ReAct and Senior Strategic Adviser, have been featured in interviews in the Bulletin of the World Health Organization April and June issues. Common themes in these interviews are the limited action on antibiotic resistance in many countries, and that the problem of antibiotic resistance needs to be viewed from a systems perspective.
In their series to portrait people working in health-related areas, the Bulletin of the World Health Organization has featured two ReAct colleagues on their experiences and contributions to the problem of antibiotic resistance.
ReAct Africa annual conference a platform in the African region
Mirfin Mpundu, head of ReAct Africa, reflected partly on his experiences as a pharmacist in both the US, Zambia and other African countries. Since 2014 he is the Executive Director of the Ecumenical Pharmaceutical Network, a faith-based organization where ReAct Africa is hosted. Mirfin described some of the key aspects of ReAct Africa’s work and how he is working to support the development of National Action Plans on Antimicrobial Resistance (AMR) in several Africa countries, as well as how the ReAct Africa annual conference serves as a platform for bringing national champions on antimicrobial resistance together.
Mirfin Mpundu says:
” We now have about 25 countries in Africa that have National Action Plans, but there are only three or four that are actually implementing them. Similarly, we still have a long way to go in terms of mainstreaming antimicrobial resistance initiatives into health systems.”
AMR is a global system problem
Otto Cars, founder of ReAct and senior strategic adviser, gave his perspectives on the very slow progress of raising the problem of antibiotic resistance to the global attention and why ReAct was set up. A key element throughout Otto’s reflections was the systems perspective. To view antimicrobial resistance as a system problem is important from several perspectives.
As Otto Cars states:
“Any effort to move towards universal health coverage must take into account the many ways in which antimicrobial resistance will impact health systems as countries expand coverage and access. We also need to look beyond health, because AMR is an agricultural sector issue too, as well as an ecological issue.”
Another systems perspective is that there is a need to transform the broken eco-systems for innovation and development of new antibiotics.
“AMR is the result of multiple system failures and can only be managed by balancing innovation, access and conservation.”
AMR is a development issue
Finally, as AMR will have an impact on many systems that are critical for global development, we need to make clear that antimicrobial resistance is a development issue.
Otto Cars says:
“I also believe we need to open a dialogue with ministers of finance and development, making it clear that AMR is a development issue and the costs of not addressing it will be high, both in terms of human health and economic growth.”
In relation to what Mirfin brought up on the slow progress of action in implementing national action plans, Otto reflects on the needs for financing for capacity building at country level:
“There are national action plans in over 100 countries, but only around a fifth of these action plans are properly funded. I support the idea of mobilizing external catalytic funding to galvanize the implementation of national action plans.”
More news and opinion
- 2019 AMR photo competition prizes announced
- Launch of UNICEF’s institutional guidance on antimicrobial resistance
- Proposed ban on colistin for animal use announced in Indonesia
- School children led celebration of World Toilet Day and World Antibiotic Awareness Week
- 10 Innovate4AMR-winning teams enjoyed 3-day workshop in Geneva
- After 4 collaborative meeting days: Actions for the future in Latin America
- Four key points from joint comments to One Health Global Leaders Group on AMR
- Why are children more vulnerable to AMR?
- Dr Yoel Lubell, Health Economist, on Thailand, AMR, UCH and cultural factors driving AMR
- UHC and AMR: The Thai Experience
- Why do effective antibiotics matter for quality of care and patient safety?
- New ReAct policy brief: Antimicrobial resistance and universal health coverage – What’s the deal?
- Three key takeaways from the ReAct Africa conference
- Diagnostics: Species identification
- AMR-specific indicator proposed for monitoring Sustainable Development Goals
- Five focus areas at the 2nd Ministerial Conference on AMR hosted by the Netherlands
- Safety concerns of fecal microbiota transplants
- Upcoming ReAct Africa Conference: universal health coverage and antimicrobial resistance in focus
- Mother Earth conference in Argentina – the environment in focus
- Diagnostics: What are we talking about?
- Connecting global to local civil-society-agenda on AMR at CSO convening in Geneva
- ReAct colleagues featured in WHO Bulletin as leading profiles in the work on reacting to antibiotic resistance
- RAN stakeholder at WHO IPC consultation – for standards and guidelines in African Union member states
- WHA conversation on Antibiotic Resistance as a Global Development Problem co-organized by ReAct
- 8 insights from ReAct Asia Pacific project on antibiotic stewardship in secondary level hospitals in India
- Open letter to UN Member States from former IACG members Anthony So and Otto Cars
- ReAct UHC Intervention at UNGA Multi-stakeholder Hearing for High-level Meeting on UHC
- ReAct Latin America honors Earth Day
- Medicines Patent Pool’s view on the role of licenses for antibiotics – World Intellectual Property Day
- Second time for Innovate4AMR competition!
- World Health Day 2019: Universal Health Coverage
- Diagnostics: Constraints for successful implementation
- Antibiotic Shortages: magnitude, causes and possible solutions: A new WHO meeting report
- Erry Setyawan, FAO, on Indonesian NAP: We need to work together to make it possible to manage AMR
- ReAct’s new 5-year strategic plan receives funding from Sida
- How infections spread and how to stop them
- Generating data for policy and practice